Cointime

  • Новости
  • заголовки
  • Кавычки
  • Столбец
  • Активность
  • Bitcoin $66,836.20 +0.48%
  • Ethereum $2,050.86 +0.21%
  • BNB $587.59 +0.60%
  • Optimism $0.11 +3.30%
  • Arbitrum $0.09 +1.04%
  • Solana $80.11 +1.27%
  • Polygon $0.22 +2.77%
  • Cosmos $1.69 +1.15%
  • Avalanche $8.87 +1.37%
  • Bitcoin $66,836.20 +0.48%
  • Ethereum $2,050.86 +0.21%
  • BNB $587.59 +0.60%
  • Optimism $0.11 +3.30%
  • Arbitrum $0.09 +1.04%
  • Solana $80.11 +1.27%
  • Polygon $0.22 +2.77%
  • Cosmos $1.69 +1.15%
  • Avalanche $8.87 +1.37%
Home / Neumora Therapeutics / investors

Neumora Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
3
17
Neumora Therapeutics is funded by 17 investors. Mubadala Capital Ventures and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Mubadala Capital Ventures Yes Series B
ARCH Venture Partners - Series B
Abu Dhabi Growth Fund - Series B
Altitude Life Science Ventures - Series B
Amgen - Series B
EXOR N.V. - Series B
F-Prime Capital - Series B
Invus - Series B
Newpath Management - Series B
Polaris Partners - Series B
Alexandria Venture Investments - Series A
Catalio Capital Management - Series A
Logos Capital - Series A
re.Mind Capital - Series A
SoftBank Vision Fund - Series A
Surveyor Capital - Series A
Waycross Ventures - Series A

Contact

Watertown,Massachusetts,United States
Cointime
Содержание
  • Новости
  • венчурный капитал
  • Отраслевые исследования
  • наука и технология
  • Активность
компания
  • о нас
  • Рекламное сотрудничество
  • Отказ от ответственности
  • © 2023 Cointime. все права защищены
  • политика конфиденциальности
  • Условия использования